June 2023 - BioMedWire (BMW)

FridayJun 30, 2023 10:49 am

Immunotherapy Implants Could Turn Tumor Cells on Each Other

Immunotherapy is a relatively recent type of cancer treatment that involves boosting the immune system to make it more effective at finding and killing cancer cells. It is often deployed together with other treatments such as chemotherapy to kill off as many cancer cells as possible and prevent them from growing. However, treating solid tumors using immunotherapy can be extremely difficult as tumors are heterogeneous, meaning each person’s tumor is different. This makes it harder to create general “one size fits all” treatments for cancer patients, even when they are suffering from the same type of cancer. A research team…

ThursdayJun 29, 2023 10:44 am

Exploring the Link Between Hypertension, Asthma

On average, asthma affects close to 26 million people, or 1 in every 13 people in the United States with nearly 21 million adults aged 18 years and older suffering from the respiratory condition. Doctors advise most asthma patients to follow steps such as religiously taking medication, implementing healthy lifestyle habits, and avoiding triggers to keep the condition under control and prevent asthma attacks. Asthma patients are also advised to keep an eye on their blood pressure numbers as hypertension is closely tied to the presence of asthma. Hypertension, or high blood pressure, is characterized by chest pain, severe headaches,…

WednesdayJun 28, 2023 1:08 pm

How to Make the Most of Your Health Savings Account

As the cost of healthcare continues to rise and inflation continues to increase, finding ways to save money will benefit many. Given that those with health savings accounts, commonly referred to as HSAs, can contribute more following recent increases to the limits to people’s contributions to HSAs, Health-E Commerce has shared some tips to maximize value from these limit increases. Health-E Commerce is the parent company of HSA Store, WellDeservedHealth and FSA Store, a collection of digital marketplaces that serve millions of consumers registered in pretax medical as well as wellness accounts. These tips include: Using online tools to project…

TuesdayJun 27, 2023 12:10 pm

Study Concludes Early Eczema Points to Future Allergy Development

German researchers recently published a study indicating that the presence of eczema in early childhood can lead to the development of allergies in the future. Also known as atopic dermatitis or atopic eczema, the skin condition affects up to 20% of children, or roughly 9.6 million children under 18 in the United States. Children are more likely to develop eczema than adults, and around one-third of them will experience moderate to severe symptoms of eczema once the condition manifests. Research findings published in the “Nutrients” journal examined the potential long-term effects of developing eczema in the first three years of…

MondayJun 26, 2023 11:56 am

Virus Therapy Plus Radiation Could Improve Brain Tumor Treatment, Study Finds

University of Alberta researchers may have devised an extra-effective brain tumor treatment by combining radiation therapy with a cancer-targeting virus. The researchers found that the combination of both treatments was more effective at treating brain cancer in mice than taking the treatments separately, indicating that scientists could develop effective cancer treatments by combining existing therapies. Brain cancer is a deadly disease that is characterized by the development and spread of tumors in the brain and has exceedingly poor health outcomes. Like most cancers, brain tumors have no cure. Most treatment efforts involve killing off as many cancer cells as possible…

FridayJun 23, 2023 10:02 am

Why Women with MS See Decreased Symptoms When Pregnant

Most people with multiple sclerosis (MS) are women (74%), while men comprise only 24% of MS patients. Women are three times more likely to develop multiple sclerosis, and the National Multiple Sclerosis Society states that more women are developing the condition as time passes. Although we still haven’t figured out what exactly causes MS, researchers posit that factors such as stress, smoking, hormones such as estrogen, and inflammation may increase the risk of developing multiple sclerosis. Many women with the condition have noticed that their symptoms decrease when they are pregnant, with some reporting a significant reduction in symptoms during…

FridayJun 23, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) CMO Discusses Recent Company Announcements in Bell2Bell Podcast Episode

Genprex Chief Medical Officer, Dr. Mark Berger, was featured in a recent Bell2Bell Podcast episode, where he discussed the company’s recent announcements In May, the company received Safety Review Committee (“SRC”) approval to advance to the Phase 2 expansion portion of its Acclaim-1 clinical trial of its lead candidate, REQORSA(R) Immunogene Therapy The Phase 1 dose escalation portion of the study showed that REQORSA(R) was generally well tolerated, and there were no dose-limiting toxicities; Genprex also reported encouraging evidence of efficacy in this portion In April, Genprex announced that its research collaborators presented in vivo mouse data showing that Genprex’s…

ThursdayJun 22, 2023 11:16 am

Armistice Capital LLC Cuts Stake in Shopify by 59%

Last week, a well-known hedge fund based in New York significantly reduced its stake in Shopify Inc. Shopify is a multinational, e-commerce company headquartered in Ontario, Canada. The company offers e-commerce solutions for micro, small and large businesses, allowing them to sell their services and products online without any hitches. The hedge fund in question, Armistice Capital LLC, is a global value-oriented and event-driven hedge fund that focuses primarily on the healthcare and consumer sectors. Armistice recently filed a report with the Securities & Exchange Commission reducing its position in Shopify by 59%. It is reported that the institutional investor…

ThursdayJun 22, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Gains Exclusive Development and Commercialization License from Max Planck for biobetter Anti-IL-17 Antibody

BiondVax just signed an exclusive worldwide license agreement with the Max Planck Society to develop and commercialize innovative NanoAb therapeutics for the treatment of psoriasis and psoriatic arthritis Part of an ongoing broad-based collaboration targeting therapies addressing diseases such as Covid-19, asthma, and macular degeneration Per BiondVax’s CEO, Amir Reichman, this exclusive license presents an exciting opportunity to develop a unique treatment for psoriasis BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products mainly for treating infectious and autoimmune diseases, just announced that it has signed an exclusive worldwide license agreement to develop…

WednesdayJun 21, 2023 11:14 am

Research Suggests Regulating Cholesterol Could Prevent Hair Loss

An estimated 85% of men will experience hair loss or male pattern baldness in their lifetimes. Even though we naturally shed and replace up to 100 strands of hair daily, this cycle is interrupted in men with male-pattern baldness, resulting in hair loss over time. Although genetics are typically the main driver for hair loss, it can also be caused by diseases such as anemia, scalp infections, chemotherapy or radiation treatments, stress and diet problems. Kerala University researchers have developed a treatment that could arrest the development of a rare type of hair loss called primary cicatricial alopecia (PCA). PCA…